SI2150538T1 - Novi substituirani hidantoini - Google Patents
Novi substituirani hidantoiniInfo
- Publication number
- SI2150538T1 SI2150538T1 SI200830641T SI200830641T SI2150538T1 SI 2150538 T1 SI2150538 T1 SI 2150538T1 SI 200830641 T SI200830641 T SI 200830641T SI 200830641 T SI200830641 T SI 200830641T SI 2150538 T1 SI2150538 T1 SI 2150538T1
- Authority
- SI
- Slovenia
- Prior art keywords
- substituted hydantoins
- novel
- preparation
- hydantoins
- substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/72—Two oxygen atoms, e.g. hydantoin
- C07D233/76—Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/72—Two oxygen atoms, e.g. hydantoin
- C07D233/76—Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
- C07D233/78—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/72—Two oxygen atoms, e.g. hydantoin
- C07D233/80—Two oxygen atoms, e.g. hydantoin with hetero atoms or acyl radicals directly attached to ring nitrogen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07109684 | 2007-06-06 | ||
| PCT/EP2008/056841 WO2008148755A2 (en) | 2007-06-06 | 2008-06-03 | Novel 5-substituted hydantoins |
| EP08760425A EP2150538B1 (en) | 2007-06-06 | 2008-06-03 | Novel 5-substituted hydantoins |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI2150538T1 true SI2150538T1 (sl) | 2012-07-31 |
Family
ID=38802392
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI200830641T SI2150538T1 (sl) | 2007-06-06 | 2008-06-03 | Novi substituirani hidantoini |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US8420683B2 (sl) |
| EP (1) | EP2150538B1 (sl) |
| CN (1) | CN101679295A (sl) |
| AT (1) | ATE551328T1 (sl) |
| HK (1) | HK1141029A1 (sl) |
| HR (1) | HRP20120460T1 (sl) |
| SI (1) | SI2150538T1 (sl) |
| WO (1) | WO2008148755A2 (sl) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2010010773A (es) | 2008-04-01 | 2011-04-11 | Abbott Gmbh & Co Kg | Tetrahidroisoquinolinas, composiciones farmaceuticas que las contienen y su uso en terapia. |
| AR075442A1 (es) | 2009-02-16 | 2011-03-30 | Abbott Gmbh & Co Kg | Derivados de aminotetralina, composiciones farmaceuticas que las contienen y sus usos en terapia |
| US9051280B2 (en) | 2010-08-13 | 2015-06-09 | AbbVie Deutschland GmbH & Co. KG | Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy |
| US9045459B2 (en) | 2010-08-13 | 2015-06-02 | AbbVie Deutschland GmbH & Co. KG | Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy |
| US8846743B2 (en) | 2010-08-13 | 2014-09-30 | Abbott Laboratories | Aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy |
| US8877794B2 (en) | 2010-08-13 | 2014-11-04 | Abbott Laboratories | Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy |
| US8883839B2 (en) | 2010-08-13 | 2014-11-11 | Abbott Laboratories | Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy |
| US9309200B2 (en) | 2011-05-12 | 2016-04-12 | AbbVie Deutschland GmbH & Co. KG | Benzazepine derivatives, pharmaceutical compositions containing them, and their use in therapy |
| TW201319049A (zh) | 2011-08-05 | 2013-05-16 | Abbott Gmbh & Co Kg | 胺基□唍、胺基硫□唍及胺基－１，２，３，４－四氫喹啉衍生物，包含彼等之醫藥組合物及彼等於治療之用途 |
| CA2853254A1 (en) | 2011-11-18 | 2013-05-23 | Abbvie Inc. | N-substituted aminobenzocycloheptene, aminotetraline, aminoindane and phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy |
| US9365512B2 (en) | 2012-02-13 | 2016-06-14 | AbbVie Deutschland GmbH & Co. KG | Isoindoline derivatives, pharmaceutical compositions containing them, and their use in therapy |
| US9650334B2 (en) | 2013-03-15 | 2017-05-16 | Abbvie Inc. | Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy |
| US9656955B2 (en) | 2013-03-15 | 2017-05-23 | Abbvie Inc. | Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy |
| AU2014336154A1 (en) | 2013-10-17 | 2016-04-28 | AbbVie Deutschland GmbH & Co. KG | Aminotetraline and aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy |
| AU2014336153A1 (en) | 2013-10-17 | 2016-04-28 | AbbVie Deutschland GmbH & Co. KG | Aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives, pharmaceutical compositions containing them, and their use in therapy |
| WO2016094846A1 (en) | 2014-12-11 | 2016-06-16 | President And Fellows Of Harvard College | Inhibitors of cellular necrosis and related methods |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4316928C2 (de) | 1993-05-19 | 1995-03-16 | Degussa | Neue Mikroorganismen, deren Verwendung und Verfahren zur Herstellung von L-alpha-Aminosäuren |
| AR036187A1 (es) * | 2001-07-24 | 2004-08-18 | Adir | Un proceso para la preparacion de perindopril, compuestos analogos y sus sales, compuesto intermediario 2,5-dioxo-oxazolidina y proceso para preparar un intermediario |
| PL367931A1 (en) | 2004-05-12 | 2005-11-14 | Instytut Farmaceutyczny | Method for manufacture of 2-[n-[(s)-1- etoxycarbonyl-3-phenyl propyl]-(s)-alanyl] -(1s,3s,5s)-2-azabicyclo [3.3.0] octane-3-carboxylic acid |
| EP2102353A2 (en) * | 2006-12-04 | 2009-09-23 | DSM IP Assets B.V. | Whole-cell catalytic system comprising a hydantoinase, a racemase and a carbamoylase |
-
2008
- 2008-06-03 WO PCT/EP2008/056841 patent/WO2008148755A2/en active Application Filing
- 2008-06-03 US US12/601,304 patent/US8420683B2/en not_active Expired - Fee Related
- 2008-06-03 EP EP08760425A patent/EP2150538B1/en not_active Not-in-force
- 2008-06-03 AT AT08760425T patent/ATE551328T1/de active
- 2008-06-03 CN CN200880019177A patent/CN101679295A/zh active Pending
- 2008-06-03 SI SI200830641T patent/SI2150538T1/sl unknown
-
2010
- 2010-08-09 HK HK10107574.7A patent/HK1141029A1/xx not_active IP Right Cessation
-
2012
- 2012-05-29 HR HRP20120460AT patent/HRP20120460T1/hr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HK1141029A1 (en) | 2010-10-29 |
| WO2008148755A2 (en) | 2008-12-11 |
| EP2150538A2 (en) | 2010-02-10 |
| ATE551328T1 (de) | 2012-04-15 |
| HRP20120460T1 (hr) | 2012-06-30 |
| WO2008148755A3 (en) | 2009-02-12 |
| CN101679295A (zh) | 2010-03-24 |
| US8420683B2 (en) | 2013-04-16 |
| US20100174092A1 (en) | 2010-07-08 |
| EP2150538B1 (en) | 2012-03-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1141029A1 (en) | Novel 5-substituted hydantoins | |
| MX2011004324A (es) | Proceso novedoso para la preparacion de derivados de aminoacidos. | |
| TN2011000370A1 (en) | Alkylamine-substituted dicyanopyridine and amino acid ester prodrugs thereof | |
| HK1148202A1 (en) | Pharmaceutical solutions, process of preparation and therapeutic uses | |
| MY147871A (en) | Chemical process for preparation of aromatic cyclopropane esters and amides | |
| GEP20135786B (en) | Pyrrole compounds | |
| SI2176253T1 (sl) | Postopek priprave ali čiščenja olmesartan medoksomila ali hidrohalidne soli olmesartan medoksomila | |
| EA201170753A1 (ru) | Налмефена гидрохлорид дигидрат | |
| JO2973B1 (en) | Fumarate salt for (alpha-beta-R) -6-bromo-alpha-[2- (methylamino) ethyl-2-methoxy-alpha-1-naphthalenyl-beta-phenyl-3-quinoline ethanol | |
| MX2009006865A (es) | Proceso para la preparacion de compuestos 6,6-dimetil-3-aza-bicicl o-[3.1.0]-hexano utilizando intermediario bisulfitico. | |
| WO2010049449A3 (en) | Novel salts of sunitinib | |
| JO2749B1 (en) | Indole-2-Wen derivatives bilaterally substituted at position 3, their preparation and therapeutic application | |
| PL2244703T3 (pl) | Lekarstwo, jego wytwarzanie i zastosowanie w leczeniu bolesnych neuropatii | |
| HK1147751A1 (en) | Carbamoylglycine derivatives | |
| MX2009008108A (es) | Composicion farmaceutica que contiene una combinacion de tramadol y ketoprofeno. | |
| MX2011006721A (es) | Formulacion farmaceutica de fenofibrato nanonizado. | |
| MX2010009290A (es) | Composicion farmaceutica. | |
| UA108277C2 (ru) | Комплексный препарат, содержащий лерканидипина гидрохлорид и валсартан, и способ его получения | |
| MD4375C1 (ro) | Procedeu de sinteză enzimatică a (7S)-1-(3,4-dimetoxibiciclo[4.2.0]octa-1,3,5-trien-7-il)-N-metil-metanaminei şi aplicarea în sinteza ivabradinei şi a sărurilor sale | |
| UA94251C2 (ru) | Индолпроизводная соль лимонной кислоты и ее фармацевтическое применение | |
| WO2010130393A3 (de) | Schmelztablette, enthaltend ein vardenafil-salz | |
| MY179041A (en) | Crystalline forms of a 3-carboxypropyl-aminotetralin compound | |
| MX2011012231A (es) | Nuevos materiales solidos del {acido[(2s.5r,8s,11s)-5-bencil-11-(3 -guanidino-propil)-8-isopropil-7-metil-3,6,9,12,15-pentaoxi-1,4,7 ,10,13-pentaaza-ciclopentadec-2-il]-acetico} y metodos para obtenerlos. | |
| MXPA05007253A (es) | Sales novedosas de derivados anticonvulsivantes. | |
| DE602008002027D1 (de) | Additionssalze von Hemmern des Angiotensin konvertierenden Enzyms mit NO abgebenden Säuren, Verfahren zu ihrer Herstellung und die sie enthaltenden pharmazeutischen Zusammensetzungen |